Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07722767 |
| Title | A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML Patients |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Cullinan Therapeutics Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | United States | Details | |
| New York University Langone Health | New York | New York | 10016 | United States | Details | |
| MD Anderson | Houston | Texas | 77030 | United States | Details |